Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Wahlbeck

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Epidemiology and Psychiatric Sciences|June 11, 2011
European comparisons between mental health servicesK Wahlbeck
Journal of Psychosomatic Obstetrics and Gynaecology|July 28, 1999
The impact of pregnancy and puerperium on panic disorder: a reviewT Hertzberg, K Wahlbeck
BMJ (Clinical Research Ed.)|March 20, 1999
Beyond conflict of interest. Sponsored drug trials show more-favourable outcomesK Wahlbeck, C Adams
Duodecim; Laaketieteellinen Aikakauskirja|January 5, 2002
[Renin-angiotensin system, discovered 100 years ago, has surprising effects on central nervous system]K Wahlbeck, R Rimón
Schizophrenia Research|March 1, 1993
Elevated angiotensin-converting enzyme (kininase II) in the cerebrospinal fluid of neuroleptic-treated schizophrenic patientsK Wahlbeck, R Rimón, F Fyhrquist
The Cochrane Database of Systematic Reviews|May 5, 2000
Beta-blocker supplementation of standard drug treatment for schizophreniaM Cheine, J Ahonen, K Wahlbeck
The Cochrane Database of Systematic Reviews|July 25, 2000
Beta-blocker supplementation of standard drug treatment for schizophreniaM Cheine, J Ahonen, K Wahlbeck
The Cochrane Database of Systematic Reviews|November 1, 2001
Beta-blocker supplementation of standard drug treatment for schizophreniaM Cheine, J Ahonen, K Wahlbeck
Acta Psychiatrica Scandinavica|April 12, 2002
Randomized controlled trials in schizophrenia: a critical perspective on the literatureS Gilbody, K Wahlbeck, C Adams
The Cochrane Database of Systematic Reviews|April 21, 2006
Glutamatergic drugs for schizophreniaH J Tuominen, J Tiihonen, K Wahlbeck
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Epidemiology and Psychiatric Sciences|June 11, 2011
European comparisons between mental health servicesK Wahlbeck
Journal of Psychosomatic Obstetrics and Gynaecology|July 28, 1999
The impact of pregnancy and puerperium on panic disorder: a reviewT Hertzberg, K Wahlbeck
BMJ (Clinical Research Ed.)|March 20, 1999
Beyond conflict of interest. Sponsored drug trials show more-favourable outcomesK Wahlbeck, C Adams
Duodecim; Laaketieteellinen Aikakauskirja|January 5, 2002
[Renin-angiotensin system, discovered 100 years ago, has surprising effects on central nervous system]K Wahlbeck, R Rimón
Schizophrenia Research|March 1, 1993
Elevated angiotensin-converting enzyme (kininase II) in the cerebrospinal fluid of neuroleptic-treated schizophrenic patientsK Wahlbeck, R Rimón, F Fyhrquist
The Cochrane Database of Systematic Reviews|May 5, 2000
Beta-blocker supplementation of standard drug treatment for schizophreniaM Cheine, J Ahonen, K Wahlbeck
The Cochrane Database of Systematic Reviews|July 25, 2000
Beta-blocker supplementation of standard drug treatment for schizophreniaM Cheine, J Ahonen, K Wahlbeck
The Cochrane Database of Systematic Reviews|November 1, 2001
Beta-blocker supplementation of standard drug treatment for schizophreniaM Cheine, J Ahonen, K Wahlbeck
Acta Psychiatrica Scandinavica|April 12, 2002
Randomized controlled trials in schizophrenia: a critical perspective on the literatureS Gilbody, K Wahlbeck, C Adams
The Cochrane Database of Systematic Reviews|April 21, 2006
Glutamatergic drugs for schizophreniaH J Tuominen, J Tiihonen, K Wahlbeck
Pageof 5